F. Van Aelst

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 648 citations · Full text

Medicine, Oncology, Pharmacology +11

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

V. Cocquyt, Simon Van Belle, Robert Reinhardt et al. · European Journal of Cancer · 2001 · 148 citations

Medicine, Pharmacology, Pharmacotherapy +5

Value of axillary ultrasonography and sonographically guided puncture of axillary nodes: A prospective study in 144 consecutive patients

J. Verbanck, Ignace Vandewiele, Hilde De Winter et al. · Journal of Clinical Ultrasound · 1997 · 88 citations

Medicine, Oncology, Radiology +16

A pulmonary infection caused by<i>Coprinus cinereus</i>(<i>Hormographiella aspergillata</i>) diagnosed after a neutropenic episode

I. Surmont, F. Van Aelst, J. Verbanck et al. · Medical Mycology · 2002 · 43 citations

Life Sciences, Infectious Diseases, Microbiology +17

A randomized phase II study of alternating and sequential regimens of docetaxel and doxorubicin as first-line chemotherapy for metastatic breast cancer

Robert Paridaens, F. Van Aelst, Vassilis Georgoulias et al. · Annals of Oncology · 2003 · 21 citations · Full text

Medicine, Oncology, Pharmacology +15